Midwest Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.64M Buy
4,470
+135
+3% +$77.6K 1.6% 15
2021
Q4
$2.89M Buy
4,335
+140
+3% +$87.4K 1.81% 11
2021
Q3
$2.4M Buy
4,195
+77
+2% +$42.3K 1.65% 15
2021
Q2
$2.08M Buy
4,118
+150
+4% +$70.8K 1.48% 21
2021
Q1
$1.81M Buy
3,968
+94
+2% +$44.9K 1.47% 22
2020
Q4
$1.8M Buy
+3,874
New +$1.82M 1.65% 18

Other funds holding TMO

Midwest Wealth Management's TMO Position: Q1 2022 in Review

Midwest Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 3.1% in Q1 2022, buying an estimated $77.6K and bringing the position to 4,470 shares worth $2.64M. The position accounts for 1.6% of the portfolio, ranked #15.

Midwest Wealth Management first reported a position in TMO in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.89M in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Midwest Wealth Management held 4,470 shares of Thermo Fisher Scientific worth $2.64M as of Q1 2022.
  • Midwest Wealth Management bought 135 Thermo Fisher Scientific shares in Q1 2022, an estimated $77.6K.
  • Thermo Fisher Scientific made up 1.6% of Midwest Wealth Management's portfolio in Q1 2022, its #15 holding.
  • Midwest Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 6 quarters since.
  • Midwest Wealth Management's Thermo Fisher Scientific position peaked at $2.89M in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Midwest Wealth Management's 13F filing for Q1 2022, filed 25 May 2022.